Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Acology Inc. (OTC: ACOL).

Full DD Report for ACOL

You must become a subscriber to view this report.


Recent News from (OTC: ACOL)

Acology Secures Canadian Patent for MedTainer(TM)
CORONA, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) announced today that their signature product, the MedTainer, has been granted a Utility Patent from the Canadian Intellectual Property Office. The Canadian patent allows Acology to move forward with their p...
Source: GlobeNewswire
Date: April, 30 2018 08:30
Acology Purchases Entire MedTainer Intellectual Property Portfolio
CORONA, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTC:ACOL) is pleased to announce the purchase of the entire intellectual property portfolio for their signature product, the MedTainer™. The purchase includes both the U.S. design and utility patents, patents-pending in...
Source: GlobeNewswire
Date: April, 23 2018 08:30
Acology 10K Highlights Accomplishments, Looks Confidently Forward
CORONA, Calif., April 02, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) released its 2017 10K report today, highlighted by steady growth and proportionately lowered operating expenses. In terms of the bottom line, investors should be pleased to note that Acology continues to gr...
Source: GlobeNewswire
Date: April, 02 2018 09:00
Big Leap for LP MedTainer Orders; California Ramps Up
CORONA, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) revealed today that Canadian licensed producers Aurora Cannabis Inc., OrganiGram and Tilray have posted March orders for more than 30,000 MedTainers, a sharp increase from initial orders made earlier this year...
Source: GlobeNewswire
Date: March, 12 2018 08:30
269 Marijuana Stocks: Correction, Crash, Or Slow Descent?
The Macroeconomic Outlook and Marijuana Stocks Diversify, but with a long-term focus on the horizon. Equities will remain good, and cannabis and marijuana stocks should remain and represent a significant part of your long-term investment portfolio. Presently, they are likely to be fairly val...
Source: SeekingAlpha
Date: February, 21 2018 22:51
Acology's Perfect Package: MedTainer Confirmed Compliant for US, Canada and Mexico
CORONA, Calif, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTCMARKETS:ACOL) confirmed today that its signature product, the MedTainer™, is compliant for the entire North American market, and specifically for the growing Canadian cannabis market, for child-resistance and material ...
Source: GlobeNewswire
Date: February, 20 2018 08:30
268 Marijuana Stocks: Learn From An Examination Of Event Dates For The Prior 52 Weeks
History Repeats This article is designed to assist you with decision-making when deciding when to [1] enter, [2] exit, and [3] whether to hold through future statements made by U.S. Attorney General Jeff Sessions and [4] January Effects. I still anticipate an upward drift for the sector th...
Source: SeekingAlpha
Date: February, 07 2018 12:45
261 Marijuana Stocks: Jeff Slowed Us Down, But 32% In Less Than 30 Days Is Not Bad
What Happened in 2017 I documented the 51% January 2017 returns in this Seeking Alpha article . I credited U.S. Attorney General Jeff Sessions with killing the rally, on February 23, 2017 , in this Seeking Alpha article . I expected the see a rally begin, again, after tax loss...
Source: SeekingAlpha
Date: January, 30 2018 07:33
260 Marijuana Stocks: Equal-Weighted Portfolio Up Nearly 7% For The Week Ending January 19, 2018
I Still Day-Trade and Like the Marijuana Sector, but I Want a Bit of Safety, as Well As we prepare for 3 or 4 Federal Reserve interest rate increases for calendar year 2018, I am easing out of my Fidelity mutual funds. At the age of 60, I find myself focusing on capital preservation, and w...
Source: SeekingAlpha
Date: January, 22 2018 05:36
Acology Canada Markets Heat Up, Big Sales Increases, LPs On Board
CORONA, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Acology Inc. (OTC MARKETS:ACOL) reports sharp increases in sales throughout Canada as the country edges towards total legalization later this year. Sales of Acology’s Signature product, the Medtainer™ are far outpacing the mark...
Source: GlobeNewswire
Date: January, 16 2018 08:30

 


About Acology Inc. (OTC: ACOL)

Logo for Acology Inc. (OTC: ACOL)

Acology, Inc. represents itself as a innovative company operating in the fields of manufacturing, branding, sales, consulting and has most recently brought a revolutionary design to the forefront, the first ever polypropylene PP air tight, water tight , smell proof delivery and storage system which also embodies a grinding component. Acology Containers give consumers the ability to store, carry, and dispense items such as pharmaceuticals, herbal remedies, teas and many other solid and/or liquid contents with ease.

 

Contact Information

 

 

Current Management

  • Curtis Fairbrother / CEO, CFO
  • Douglas Heldoorn / COO
  • Barry Miller / Secretary
  • Curtis Fairbrother / Chairman

Current Share Structure

  • Market Cap: $59,634,446 - 03/15/2018
  • Authorized: 6,000,000,000 - 08/11/2016
  • Issue and Outstanding: 5,249,511,090 - 11/07/2017
  • Float: 700,049,785 - 04/15/2015

 


Recent Filings from (OTC: ACOL)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 03 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Non-EDGAR filing submitted by "insiders" prior to intended sale of restricted stock
Filing Type: 144Filing Source: edgar
Filing Date: March, 14 2018
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: January, 05 2018
Correspondence from the SEC to the Filer
Filing Type: UPLOADFiling Source: edgar
Filing Date: November, 28 2017
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: November, 24 2017
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: November, 24 2017
Amendment to a previously filed 10-Q
Filing Type: 10-Q/AFiling Source: edgar
Filing Date: November, 24 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 08 2017
Correspondence from the Filer to the SEC
Filing Type: CORRESPFiling Source: edgar
Filing Date: November, 03 2017

 

 


Daily Technical Chart for (OTC: ACOL)

Daily Technical Chart for (OTC: ACOL)


Stay tuned for daily updates and more on (OTC: ACOL)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: ACOL)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ACOL is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of ACOL and does not buy, sell, or trade any shares of ACOL. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/